Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Altering source or amount of dietary carbohydrate has acute and chronic effects on postprandial glucose and triglycerides in type 2 diabetes: Canadian trial of Carbohydrates in Diabetes (CCD).
Wolever TM, Gibbs AL, Chiasson JL, Connelly PW, Josse RG, Leiter LA, Maheux P, Rabasa-Lhoret R, Rodger NW, Ryan EA. Wolever TM, et al. Among authors: maheux p. Nutr Metab Cardiovasc Dis. 2013 Mar;23(3):227-34. doi: 10.1016/j.numecd.2011.12.011. Epub 2012 Mar 6. Nutr Metab Cardiovasc Dis. 2013. PMID: 22397878 Clinical Trial.
The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein.
Wolever TM, Gibbs AL, Mehling C, Chiasson JL, Connelly PW, Josse RG, Leiter LA, Maheux P, Rabasa-Lhoret R, Rodger NW, Ryan EA. Wolever TM, et al. Among authors: maheux p. Am J Clin Nutr. 2008 Jan;87(1):114-25. doi: 10.1093/ajcn/87.1.114. Am J Clin Nutr. 2008. PMID: 18175744 Free article. Clinical Trial.
Effects of Changing the Amount and Source of Dietary Carbohydrates on Symptoms and Dietary Satisfaction Over a 1-Year Period in Subjects with Type 2 Diabetes: Canadian Trial of Carbohydrates in Diabetes (CCD).
Wolever TM, Chiasson JL, Josse RG, Leiter LA, Maheux P, Rabasa-Lhoret R, Rodger NW, Ryan EA. Wolever TM, et al. Among authors: maheux p. Can J Diabetes. 2017 Apr;41(2):164-176. doi: 10.1016/j.jcjd.2016.08.223. Epub 2016 Nov 21. Can J Diabetes. 2017. PMID: 27884550 Clinical Trial.
Genetic polymorphisms of tumor necrosis factor-alpha modify the association between dietary polyunsaturated fatty acids and fasting HDL-cholesterol and apo A-I concentrations.
Fontaine-Bisson B, Wolever TM, Chiasson JL, Rabasa-Lhoret R, Maheux P, Josse RG, Leiter LA, Rodger NW, Ryan EA, Connelly PW, Corey PN, El-Sohemy A. Fontaine-Bisson B, et al. Among authors: maheux p. Am J Clin Nutr. 2007 Sep;86(3):768-74. doi: 10.1093/ajcn/86.3.768. Am J Clin Nutr. 2007. PMID: 17823444 Free article.
Effect of acarbose on insulin sensitivity in elderly patients with diabetes.
Meneilly GS, Ryan EA, Radziuk J, Lau DC, Yale JF, Morais J, Chiasson JL, Rabasa-Lhoret R, Maheux P, Tessier D, Wolever T, Josse RG, Elahi D. Meneilly GS, et al. Among authors: maheux p. Diabetes Care. 2000 Aug;23(8):1162-7. doi: 10.2337/diacare.23.8.1162. Diabetes Care. 2000. PMID: 10937515 Clinical Trial.
Acarbose in the treatment of elderly patients with type 2 diabetes.
Josse RG, Chiasson JL, Ryan EA, Lau DC, Ross SA, Yale JF, Leiter LA, Maheux P, Tessier D, Wolever TM, Gerstein H, Rodger NW, Dornan JM, Murphy LJ, Rabasa-Lhoret R, Meneilly GS. Josse RG, et al. Among authors: maheux p. Diabetes Res Clin Pract. 2003 Jan;59(1):37-42. doi: 10.1016/s0168-8227(02)00176-6. Diabetes Res Clin Pract. 2003. PMID: 12482640 Clinical Trial.
58 results